News

ADI is sharing a snapshot of the Asia Pacific region’s activities during World Alzheimer’s Month this year. From memory walks, to dementia screenings, to concerts, ADI has been delighted to see such a broad variety of activities dedicated to raising awareness of dementia in the region.  With opening words from ADI’s Regional Director for Asia Pacific, we are reporting the multiple actions and efforts that have been taken across the region.

As the World Alzheimer’s Month 2024 campaign draws to close, ADI is proud to report on this year’s achievements from our global community as we united to focus on the urgent message: "Time to act on dementia." With over 81 million global impressions and 4,000 mentions in the media, the campaign brought together dementia associations, advocates, professionals, and carers to raise awareness and reduce stigma to hold events worldwide, including memory walks, exhibitions, presentations, and illuminated landmarks that highlighted the importance of addressing dementia stigma. To all that have taken part, we would like to say thank you for another World Alzheimer’s Month filled with global action.

The UK medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the marketing authorisation for lecanemab in the treatment of early Alzheimer’s disease. However, the treatment will not be available through the National Health Service (NHS), the UK’s publicly funded health agency.

ADI’s Diego Aguilar and Nick House attend the Alzheimer's Association International Conference in Philadelphia (USA), delivering key insights, conducting vital meetings and advocating for care in the era of new treatments.

In May 2024, the ADI delegation returned to Geneva, Switzerland, for the World Health Organization’s 77th annual World Health Assembly to launch ’From Plan To Impact VII: Dementia at a crossroads’. Read ADI's highlights from the event.

In under a year, Brazil has made giant leaps in the development of its own National Dementia Plan, culminating in legislation signed by President  Luiz Inácio Lula da Silva on 4 June, 2024. ADI revisits the journey that we have shared with our Brazilian member association, Febraz, to help make this plan a reality. 

ADI is sharing a round-up of our recent action in Europe, on advocacy and research, with ADI Board Vice Chair, Meera Pattabiraman, and ADI Director of Research and Publications, Wendy Weidner. Both taking part in vital dialogues in June 2024. 

Regional Director for the Americas, Diego Aguilar, alongside politician and neuroscientist Facundo Manes, and ADI’s Argentinian member association A.L.M.A, joined for urgent action on dementia following steeply increasing dementia forecasts and stalling progress towards a National Dementia Plan in the country.